Importantly, the gene set (SAA1, SAA2, APOL1, and MET) that characterizes metastatic ccRCC from previous studies exhibited significant expression in the MT + group (Alchahin et al., 2022) (Figure 3T). The gene discussed is APOL1; the disease is nonpapillary renal cell carcinoma.